Penumbra Inc - Asset Resilience Ratio
Penumbra Inc (PEN) has an Asset Resilience Ratio of 19.72% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check PEN strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Penumbra Inc's Asset Resilience Ratio has changed over time. See Penumbra Inc (PEN) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Penumbra Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Penumbra Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $374.37 Million | 19.72% |
| Total Liquid Assets | $374.37 Million | 19.72% |
Asset Resilience Insights
- Good Liquidity Position: Penumbra Inc maintains a healthy 19.72% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Penumbra Inc Industry Peers by Asset Resilience Ratio
Compare Penumbra Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Penumbra Inc (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Penumbra Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 29.83% | $544.82 Million | $1.83 Billion | +7.64pp |
| 2024-12-31 | 22.18% | $340.13 Million | $1.53 Billion | +3.60pp |
| 2023-12-31 | 18.58% | $289.19 Million | $1.56 Billion | +4.87pp |
| 2022-12-31 | 13.72% | $188.03 Million | $1.37 Billion | -6.77pp |
| 2021-12-31 | 20.48% | $254.88 Million | $1.24 Billion | -11.70pp |
| 2020-12-31 | 32.18% | $264.83 Million | $822.98 Million | +3.74pp |
| 2019-12-31 | 28.44% | $189.39 Million | $665.90 Million | -10.57pp |
| 2018-12-31 | 39.01% | $200.89 Million | $515.01 Million | -6.01pp |
| 2017-12-31 | 45.02% | $214.59 Million | $476.67 Million | +3.25pp |
| 2016-12-31 | 41.77% | $128.75 Million | $308.25 Million | -7.22pp |
| 2015-12-31 | 48.99% | $129.26 Million | $263.85 Million | +9.24pp |
| 2014-12-31 | 39.75% | $48.25 Million | $121.38 Million | +26.34pp |
| 2013-12-31 | 13.42% | $9.54 Million | $71.15 Million | -- |
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more